Latest filing published 03 Apr 2015 for Eiger BioPharmaceuticals, Inc., €4,621.
Insider track record
No signal scores available.
Ryan K. Takeya: trading record in brief
Ryan K. Takeya appears in our data through filings on Eiger BioPharmaceuticals, Inc. shares, published by SEC (Form 4). Between 1 December 2014 and 1 April 2015, the trades on record add up to 10 filings.
Every open-market trade on record is a sale: 5 sales worth €523k. Other entries cover 5 option exercises. So far in 2015, the count stands at no purchases and 4 sales.
The newest entry dates from 3 April 2015: an option exercise of €4,621, in Eiger BioPharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ryan K. Takeya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,444 shares@ US$1.12Common StockSEC:0001209191-15-032248:0
- 4,444 shares@ US$19.13Common StockSEC:0001209191-15-032248:1
- 7,777 shares@ US$1.12Common StockSEC:0001209191-15-021906:0
- 7,777 shares@ US$18.48Common StockSEC:0001209191-15-021906:1
- 7,777 shares@ US$1.12Common StockSEC:0001209191-15-009079:0
- 7,777 shares@ US$16.35Common StockSEC:0001209191-15-009079:1
- 7,777 shares@ US$1.12Common StockSEC:0001209191-15-001704:0
- 7,777 shares@ US$19.88Common StockSEC:0001209191-15-001704:1
- 7,777 shares@ US$1.12Common StockSEC:0001209191-14-072480:0
- 7,777 shares@ US$12.01Common StockSEC:0001209191-14-072480:1
10 of 10 declarations
